You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Parathyroid disorders

Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy

  • Technology appraisal guidance
  • Reference number: TA117
  • Published:  24 January 2007
  • Guidance
  • Tools and resources
  • Information for the public
  • History

TA117 Hyperparathyroidism - cinacalcet: Appendix A - provisional matrix of stakeholders

TA117 Hyperparathyroidism - cinacalcet: Appendix A - provisional matrix of stakeholders TA117 Hyperparathyroidism - cinacalcet: Appendix A - provisional matrix of stakeholders
29 April 2013
(37.25 Kb 10 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 26 April 2013

Back to top